Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
ABB Ltd | ABJA | 21. nov 2024 | 53.50 | +2.88 |
Abbott Laboratories | ABL | 21. nov 2024 | 109.68 | -0.71 |
AbbVie Inc. | 4AB | 21. nov 2024 | 164.12 | +3.78 |
ABC | EK7 | 21. nov 2024 | 0.42 | +1.01 |
ABC Arbitrage | 9BA | 21. nov 2024 | 4.74 | -0.32 |
ABC-Mart Inc. | 5B8 | 21. nov 2024 | 18.10 | -0.55 |
AbCellera Biologics Inc. - | 8QQ | 21. nov 2024 | 2.50 | -0.99 |
Abcourt Mines, Inc. | AML | 21. nov 2024 | 0.03 | +13.33 |
ABEN MINERALS LTD | R26 | 21. nov 2024 | 0.03 | -10.61 |
Abercrombie & Fitch Company | AFT | 21. nov 2024 | 132.90 | +1.26 |
Aberdeen Asia-Pacific Income Fund Inc | 9J9 | 21. nov 2024 | 2.40 | 0.00 |
Aberdeen Asia-Pacificome Fund | 9J90 | 21. nov 2024 | 14.44 | 0.00 |
Aberdeen International Inc | A8H | 21. nov 2024 | 0.03 | +23.26 |
Aberdeen Standard European Logistics Income Plc | 5JX | 21. nov 2024 | 0.69 | 0.00 |
Aberforth Smaller Companies Trust PLC | 0KJ | 21. nov 2024 | 17.00 | -0.58 |
ABG Sundal Collier Holding | DAB | 21. nov 2024 | 0.56 | -3.78 |
Abionyx Pharma | 609 | 21. nov 2024 | 1.22 | -2.56 |
Abitare In Spa | 1BN | 21. nov 2024 | 4.14 | +2.73 |
ABITIBI METALS CORP. | FW0 | 21. nov 2024 | 0.24 | -3.27 |
Abivax | 2X1 | 21. nov 2024 | 8.23 | +1.35 |
ABIVAX SA SP.ADR EO -,01 | 2X10 | 21. nov 2024 | 8.10 | +4.52 |
ABL Group ASA | 26Q | 21. nov 2024 | 0.77 | +0.52 |
Abliva | NTP | 21. nov 2024 | 0.00 | -6.67 |
ABM Industries Incorporated | AB4 | 21. nov 2024 | 53.50 | +1.90 |
ABN AMRO Bank N.V. | AB2 | 21. nov 2024 | 14.68 | -1.48 |
ABN AMRO BK.UNSP.ADR/1 | AB2A | 21. nov 2024 | 14.50 | 0.00 |
ABO Wind AG | AB9 | 21. nov 2024 | 38.00 | +8.26 |
ABO-Group | 3T61 | 21. nov 2024 | 5.05 | 0.00 |
ABOUT YOU HOLDING AG | YOU | 21. nov 2024 | 3.19 | 0.00 |
Absa Group Limited | AU61 | 21. nov 2024 | 9.15 | +5.78 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.